Ganesan Munyandithevar

Ganesan Munyandithevar

Active Director Director DIN 01678784
DIN 01678784 First appointment Jun 2005 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Jun 2005
Shareholding value •••• Premium profile

About Ganesan Munyandithevar

Data last updated:

Ganesan Munyandithevar is a Director at Kms Health Center Private Limited (since 2013), Managing Director at Micro Therapeutic Research Labs Private Limited (since 2005) and Director at Luminol Biopharma Private Limited (since 2017), and holds 1 more current directorship. The companies operate in Pharma, Life Sciences and Education. The 4 current companies with reported revenue have a combined latest revenue of ₹16.63 Cr; the largest is Kms Health Center Private Limited at ₹9.90 Cr (FY 2024). Earlier, Ganesan Munyandithevar was a Managing Director at Regenix Health Care Limited (2010–2011).

DIN 01678784
Primary Designation Director
Industry Pharma
First Appointment 06 Jun 2005
Oldest Company Age 21 yrs
Largest company Kms Health Center Private Limited · ₹9.90 Cr (FY 2024)
Combined revenue ₹16.63 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kms Health Center Private Limited U85100TN2011PTC113647
Director27 Nov 20132011₹9.90 Cr (FY 2024)Active
Managing Director06 Jun 20052005₹6.34 Cr (FY 2025)Active
Luminol Biopharma Private Limited U24304TN2017PTC116722
Director24 May 20172017₹38.4 Lakh (FY 2024)Active
Director29 Jan 20092009₹38,100 (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Regenix Health Care Limited U24100TN2005PLC057698
Managing Director18 Jan 20102005Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Ganesan Munyandithevar

Directorship timeline

Open interactive timeline →
Luminol Biopharma Private Limited
Sri Sai Clinical Research Institute Private Limited
Kms Health Center Private Limited
Micro Therapeutic Research Labs Private Limited
Premium access

Shareholding and investment profile for Ganesan Munyandithevar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ganesan Munyandithevar

Ganesan Munyandithevar currently holds 4 directorships: Kms Health Center Private Limited (Director, since 27 Nov 2013, revenue ₹9.90 Cr (FY 2024)); Micro Therapeutic Research Labs Private Limited (Managing Director, since 06 Jun 2005, revenue ₹6.34 Cr (FY 2025)); Luminol Biopharma Private Limited (Director, since 24 May 2017, revenue ₹38.4 Lakh (FY 2024)); Sri Sai Clinical Research Institute Private Limited (Director, since 29 Jan 2009, revenue ₹38,100 (FY 2024)).

Ganesan Munyandithevar was first appointed on 06 Jun 2005 as Managing Director at Micro Therapeutic Research Labs Private Limited. The most recent appointment on record is 24 May 2017 at Luminol Biopharma Private Limited.

The 4 current companies of Ganesan Munyandithevar that report revenue have a combined latest revenue of ₹16.63 Cr: Kms Health Center Private Limited ₹9.90 Cr (FY 2024); Micro Therapeutic Research Labs Private Limited ₹6.34 Cr (FY 2025); Luminol Biopharma Private Limited ₹38.4 Lakh (FY 2024); Sri Sai Clinical Research Institute Private Limited ₹38,100 (FY 2024).

Ganesan Munyandithevar held 1 earlier board appointment: Regenix Health Care Limited (Managing Director, 18 Jan 2010 to 01 Aug 2011).

The current boards of Ganesan Munyandithevar's companies include Vasanthi Gunasekaran (Kms Health Center Private Limited), Kalarani Ganesan (Micro Therapeutic Research Labs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available